Consun Pharmaceutical Group Past Earnings Performance

Past criteria checks 4/6

Consun Pharmaceutical Group has been growing earnings at an average annual rate of 25.8%, while the Pharmaceuticals industry saw earnings growing at 1.2% annually. Revenues have been growing at an average rate of 10.5% per year. Consun Pharmaceutical Group's return on equity is 21%, and it has net margins of 30.5%.

Key information

25.8%

Earnings growth rate

26.9%

EPS growth rate

Pharmaceuticals Industry Growth	6.0%
Revenue growth rate	10.5%
Return on equity	21.0%
Net Margin	30.5%
Last Earnings Update	30 Jun 2024

Recent past performance updates

No updates

Recent updates

No updates

Revenue & Expenses Breakdown

How Consun Pharmaceutical Group makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

OTCPK:CPHG.F Revenue, expenses and earnings (CNY Millions)
Date	Revenue	Earnings	G+A Expenses
30 Jun 24	2,739	836	1,211
31 Mar 24	2,665	810	1,183
31 Dec 23	2,590	785	1,155
30 Sep 23	2,528	759	1,124
30 Jun 23	2,466	734	1,093
31 Mar 23	2,403	708	1,078
31 Dec 22	2,340	683	1,062
30 Sep 22	2,246	660	1,008
30 Jun 22	2,152	636	954
31 Mar 22	2,098	613	918
31 Dec 21	2,045	590	882
30 Sep 21	1,959	565	855
30 Jun 21	1,874	541	827
31 Mar 21	1,813	520	801
31 Dec 20	1,753	499	775
30 Sep 20	1,653	269	754
30 Jun 20	1,553	39	733
31 Mar 20	1,641	60	752
31 Dec 19	1,728	80	771
30 Sep 19	1,822	288	762
30 Jun 19	1,916	496	754
31 Mar 19	1,880	481	746
31 Dec 18	1,844	465	738
30 Sep 18	1,802	448	733
30 Jun 18	1,760	430	728
31 Mar 18	1,710	413	716
31 Dec 17	1,660	396	704
30 Sep 17	1,601	372	680
30 Jun 17	1,541	347	656
31 Mar 17	1,382	327	586
31 Dec 16	1,223	308	516
30 Sep 16	1,060	291	454
30 Jun 16	896	274	392
31 Mar 16	863	262	387
31 Dec 15	831	250	382
30 Sep 15	814	246	372
30 Jun 15	798	242	362
31 Mar 15	764	226	353
31 Dec 14	731	211	345
30 Sep 14	697	198	330
30 Jun 14	664	185	315
31 Mar 14	618	169	285
31 Dec 13	572	153	256

Quality Earnings: CPHG.F has high quality earnings.

Growing Profit Margin: CPHG.F's current net profit margins (30.5%) are higher than last year (29.8%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: CPHG.F's earnings have grown significantly by 25.8% per year over the past 5 years.

Accelerating Growth: CPHG.F's earnings growth over the past year (13.9%) is below its 5-year average (25.8% per year).

Earnings vs Industry: CPHG.F earnings growth over the past year (13.9%) did not outperform the Pharmaceuticals industry 54.6%.

Return on Equity

High ROE: CPHG.F's Return on Equity (21%) is considered high.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/24 15:56
End of Day Share Price	2024/12/10 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Consun Pharmaceutical Group Limited is covered by 8 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Fangqi Dai	China Merchants Securities (HK) Co., Ltd
null null	CMB International Securities Limited
Trina Chen	Credit Suisse